Last reviewed · How we verify

NCT03806504

High PEEP Application Following Pulmonary Thromboendarterectomy; Does it Have Any Impact on Outcome?

Completed NA Last updated 7 May 2021
What this trial tests

NA trial testing PEEP in Reperfusion Injury After Pulmonary Thromboendarterektomy in 60 participants. Completed in 31 December 2019.

Timeline
1 January 2019
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment60
Start date1 January 2019
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

Who can join

Adults 20 to 70, any sex, with Reperfusion Injury After Pulmonary Thromboendarterektomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the effect of intraoperative lung protection high PEEP maneuver on ischemic reperfusion injury in patients undergoing pulmonary endarterectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PEEP

Trials testing the same drug.

Other Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing